Arachidonic acid (AA) has recently been shown to influence various cellular functions in the central nervous system. Here we report that AA increases, in a timeand concentration-dependent manner, 2-deoxy-D- [1-3H] uptake, for which the EC50 of NE is 1 IAM. Since the cerebral cortex, the brain region from which astrocytes used in this study were prepared, receives a massive noradrenergic innervation, originating from the locus coeruleus, the effects of NE reported here further stress the notion that certain neurotransmitters may play a role in the regulation of energy metabolism in the cerebral cortex and point at astrocytes as the likely targets of such metabolic effects.
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Astrocytes play an important role in the maintenance of local homeostasis within the central nervous system (1, 2) . In addition to clearing the extracellular space from K+, glutamate, or 'y-aminobutyric acid, whose levels increase as a result of neuronal activity (3) (4) (5) , astrocytes may contribute to energy metabolism homeostasis, a function already postulated over a century ago by Golgi (6) . For example, astrocytes are the cell type in which glycogen is almost exclusively stored within the central nervous system (7, 8) , and certain neurotransmitters can readily mobilize this energy reserve (9, 10) . Thus, vasoactive intestinal peptide (VIP) and norepinephrine (NE), two neurotransmitters contained in discrete neuronal populations in the cerebral cortex (11) , promote, within minutes of application, glycogenolysis in primary cultures of astrocytes (12) ; within a longer time frame (4-8 hr) , these two neurotransmitters promote glycogen resynthesis (13) . These actions of VIP and NE on astrocyte energy metabolism are mediated by the cAMP-generating signal transduction cascade (12, 13) . These observations are part of a growing body of experimental evidence indicating the presence in astrocytes of specific neurotransmitter receptors that are coupled to second messenger-generating cascades (14) , further elucidating the nature of neuron-glia interactions. A second messenger cascade that has emerged in recent years as being involved in several aspects of neural functions is the receptor-coupled phospholipase A2 (PLA2), whose activation leads to the release ofarachidonic acid (AA) from membrane phospholipids; AA may in turn become the substrate for specific cyclooxygenases and lipoxygenases to generate prostaglandins and leukotrienes, respectively (15) . Accordingly, a role for AA has been considered in long-term potentiation, ischemia, and seizures (16, 17) . AA is released by astrocytes (18) , where it has been shown to inhibit the uptake of glutamate (19) (20) (21) . Recently, studies in Swiss 3T3 fibroblasts have demonstrated that AA is an efficient stimulator of glucose uptake (22, 23) . Glucose uptake in astrocytes has been successfully examined by using 2-deoxy-D-[l-3H]glucose ([3H]2DG) as a tracer (24) (25) (26) (27) and shown to be modulated by various agents, including insulin (24) , ouabain (26) , monensin (28) , thyroid hormones (29) , and elevated extracellular K+ (30) . Given the role that astrocytes play in the regulation of energy metabolism in the central nervous system, we set out to determine the consequences of manipulating AA metabolism on glucose uptake in astrocytes. (34) . Using this method, agonist-induced release of radioactivity in the extracellular medium corresponds to 1-2% of cellular 3H content (34 (Fig. 1) . Thus, the absolute increase in [3H]2DG In fact, NDGA potentiated, although marginally, [3H]2DG uptake evoked by AA ( Table 2) .
MATERIALS AND METHODS
The levels offree AA in cells are determined by the balance between AA release from membrane phospholipids resulting from the action of specific phospholipases, notably PLA2, and by the degree ofreesterification offatty acid moieties into membrane phospholipids, a process that is catalyzed by *Significantly different from 100 AM AA alone (P < 0.001). reported (26, 30) . This rate of [3H]2DG uptake is of the same order as glucose utilization of the grey matter as determined by the 2-deoxyglucose autoradiography technique in rodent cerebral cortex, assuming a protein content of 10% for brain tissue (36) . This observation would tend to suggest that glucose utilization in the cerebral cortex as measured by the 2-deoxyglucose autoradiography technique (36) may reflect, at least in part, glucose uptake in astrocytes.
Results reported in this article have revealed two stimulators of [3H]2DG uptake in astrocytes-namely, AA and NE. The effect of AA is expressed significantly between 30 and 100 ,uM, similar to the concentrations at which AA stimulates glucose transport in 3T3 fibroblasts (22, 23) and inhibits glutamate uptake in astrocyte cultures (20 chain appears to be an absolute requirement for the expression ofthe effect, since, as noted earlier, arachidic acid (20:0; i.e., same chain length as AA but no double bond) was without effect, while another unsaturated fatty acid, linolenic acid (18:4), also promoted [3H]2DG uptake. Similar structural requirements have been reported for the effects of long-chain fatty acids on glutamate and 'y-aminobutyric acid uptake inhibition (41) as well as for Na/K-ATPase activity inhibition in the nervous system (42) . Results In the cerebral cortex, NE has been shown to stimulate the formation of cAMP followed, among other cAMP-dependent cellular actions, by glycogenolysis (11) . This regulation of glycogen metabolism is exerted in astrocytes (12) . Given the metabolic nature of glycogenolysis and of [3H]2DG uptake, a causal relation between these two actions of NE in astrocytes could be considered. However, VIP, another neurotransmitter that triggers cAMP-dependent glycogenolysis in astrocytes (9, 12) , is without effect on [3H]AA levels and [3H]2DG uptake. These results further support the notion that the activation of glucose uptake elicited by NE is related to the capacity of the monoamine to increase free AA levels, and not to its effect on cAMP or on glycogen metabolism.
The NE-containing neuronal system originates in the locus coeruleus (43, 44) . Within the cerebral cortex, the noradrenergic system adopts a general trajectory that is parallel to the pial surface, thus endowing NE-containing axons with the capacity to exert their actions throughout the cortical mantle, spanning across functionally and cytoarchitectonically distinct areas (44) . Studies in freely moving rodents and primates (44) have shown that the NE-containing neurons of the locus coeruleus are activated when the animal is exposed to unexpected, nonnoxious sensory stimulation (45) . In the course of such behavioral situations, the noradrenergic tone of the cerebral cortex is enhanced and is likely to trigger, among other actions, the increase in glucose uptake by astrocytes described here. This action, in parallel with the previously described glycogenolytic effect of NE, which also occurs in astrocytes (12) 
